Slide Deck for The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review

Matthew Halma

Main points:

  • Limited and countervailing evidence before approval Unprecedented platform (mRNA)
  • Unprecedented target (coronavirus)
  • Unprecedented speed of development

Image: Spencer Davis @ Unsplash

Latest articles

In mid-June 2024 our close friends and allies at Vaccine Choice Canada...
Image caption: Dr. Rochagné Kilian during a recent interview with Dr. Peter...
Recently we drove 220 kilometers return trip to visit a longtime gardening...
I am a 70 year old medical doctor who has practiced medicine...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!